Bbr Partners, LLC Amgen Inc Transaction History

Bbr Partners, LLC

$1.3 Billion
Q3 2024

A detailed history of Bbr Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Bbr Partners, LLC holds 6,292 shares of AMGN stock, worth $1.76 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

6,292

Previous 6,348 0.88%

Holding current value

$1.76 Million

Previous $1.98 Million 2.22%

% of portfolio

0.16%

Previous 0.16%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $17,325 - $18,893	-56 Reduced 0.88%	6,292 $2.03 Million
Q2 2024 Aug 05, 2024	SELL	$262.75 - $319.31 $189,968 - $230,861	-723 Reduced 10.22%	6,348 $1.98 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $221,817 - $267,762	825 Added 13.21%	7,071 $2.01 Million
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $150,351 - $169,614	-588 Reduced 8.6%	6,246 $1.8 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $1.49 Million - $1.86 Million	6,834 New	6,834 $1.84 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $20,830 - $23,044	95 Added 4.44%	2,235 $540,000
Q4 2021 Feb 08, 2022	BUY	$198.88 - $227.6 $80,546 - $92,178	405 Added 23.34%	2,140 $481,000
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $11,250 - $13,181	-53 Reduced 2.96%	1,735 $369,000
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $4,204 - $4,664	18 Added 1.02%	1,788 $436,000
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $665 - $775	3 Added 0.17%	1,770 $440,000
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $6,924 - $8,245	32 Added 1.84%	1,767 $406,000
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $407,117 - $452,748	1,735 New	1,735 $441,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bbr Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bbr Partners, LLC with notifications on news.

Account